|
|
|
|
|
HOME >
CORPORATE INFO > COMPANY BACKGROUND
|
|
|
|
Syncom Formulations (India) Ltd.
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
|
|
BSE Code |
524470
|
|
ISIN Demat |
INE312C01025
|
|
Book Value |
4.21
|
|
|
NSE Code |
SYNCOMF
|
|
Dividend Yield % |
0.00
|
|
Market Cap |
11233.00
|
|
|
P/E |
16.29
|
|
EPS |
0.73
|
|
Face Value |
1
|
|
|
|
|
|
|
|
|
Incorporation Year
|
21-06 1988
|
|
Registered Office
|
7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E), Mumbai, Maharashtra-400093 .
|
|
ISINNO
|
INE312C01025
|
|
Phone
|
022 30887744 / 54
|
|
E-mail
|
sfil87@syncomformulations.com |
|
URL
|
www.sfil.in |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Ankit Kedarmal Bankda
|
|
Managing Director
|
Vijay Shankarlal Bankda
|
|
Company Secretary
|
Vaishali Agrawal
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|